Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma

Published:2013-08 Issue:8 Volume:24 Page:2131-2136
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Wu X.,Huang P.Y.,Peng P.J.,Lu L.X.,Han F.,Wu S.X.,Hou X.,Zhao H.Y.,Huang Y.,Fang W.F.,Zhao Y.Y.,Xue C.,Hu Z.H.,Zhang J.,Zhang J.W.,Ma Y.X.,Liang W.H.,Zhao C.,Zhang L.

Funder

Sanofi-Synthelabo. Sanofi-Synthelabo only donated the Eloxatin for this study

Fundamental Research Funds for the State Key Laboratory of Oncology in South China

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/8/2131/13789913/mdt163.pdf

Reference19 articles.

1. The prevalence and prevention of nasopharyngeal carcinoma in China;Cao;Chin J Cancer,2011

2. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients;Baujat;Int J Radiat Oncol Biol Phys,2006